Aptus Capital Advisors’s iShares US Medical Devices ETF IHI Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$80.9K Buy
1,637
+1
+0.1% +$51 ﹤0.01% 1296
2026
Q1
$87.3K Sell
1,636
-427
-21% -$25.1K ﹤0.01% 1182
2025
Q4
$128K Buy
2,063
+1,058
+105% +$65.3K ﹤0.01% 1115
2025
Q3
$60.4K Sell
1,005
-58
-5% -$3.55K ﹤0.01% 1207
2025
Q2
$66.6K Buy
1,063
+58
+6% +$3.48K ﹤0.01% 1140
2025
Q1
$60.5K Sell
1,005
-491
-33% -$30.5K ﹤0.01% 1085
2024
Q4
$87.3K Buy
1,496
+1,205
+414% +$71.6K ﹤0.01% 1032
2024
Q3
$17.2K Hold
291
﹤0.01% 1055
2024
Q2
$16.3K Sell
291
-322
-53% -$18K ﹤0.01% 994
2024
Q1
$35.9K Buy
613
+414
+208% +$23.4K ﹤0.01% 921
2023
Q4
$10.7K Sell
199
-1,645
-89% -$80.4K ﹤0.01% 790
2023
Q3
$89.4K Buy
1,844
+1,482
+409% +$78.8K ﹤0.01% 632
2023
Q2
$20.4K Buy
362
+105
+41% +$5.78K ﹤0.01% 652
2023
Q1
$13.9K Sell
257
-92
-26% -$4.9K ﹤0.01% 659
2022
Q4
$18.3K Buy
349
+1
+0.3% +$51 ﹤0.01% 654
2022
Q3
$16K Buy
348
+150
+76% +$7.78K ﹤0.01% 626
2022
Q2
$10K Hold
198
﹤0.01% 570
2022
Q1
$12K Hold
198
﹤0.01% 594
2021
Q4
$13K Hold
198
﹤0.01% 488
2021
Q3
$12K Sell
198
-120
-38% -$7.66K ﹤0.01% 469
2021
Q2
$19K Hold
318
﹤0.01% 467
2021
Q1
$18K Hold
318
﹤0.01% 434
2020
Q4
$16K Hold
318
﹤0.01% 397
2020
Q3
$15K Buy
318
+198
+165% +$9.59K ﹤0.01% 401
2020
Q2
$5K Hold
120
﹤0.01% 385
2020
Q1
$4K Hold
120
﹤0.01% 383
2019
Q4
$5K Hold
120
﹤0.01% 469
2019
Q3
$4K Buy
+120
New +$4.91K ﹤0.01% 454

Other funds holding IHI

Aptus Capital Advisors's IHI Position: Q2 2026 in Review

Aptus Capital Advisors increased its iShares US Medical Devices ETF (IHI) stake by 0.06% in Q2 2026, buying an estimated $51 and bringing the position to 1,637 shares worth $80.9K. The position accounts for ﹤0.01% of the portfolio, ranked #1296.

Aptus Capital Advisors first reported a position in IHI in Q3 2019 and has held it in 28 quarters since. The position peaked at $128K in Q4 2025. 500 funds tracked by Wall St. Rank hold IHI as of Q2 2026.

  • Aptus Capital Advisors held 1,637 shares of iShares US Medical Devices ETF worth $80.9K as of Q2 2026.
  • Aptus Capital Advisors bought 1 iShares US Medical Devices ETF share in Q2 2026, an estimated $51.
  • iShares US Medical Devices ETF made up ﹤0.01% of Aptus Capital Advisors's portfolio in Q2 2026, its #1296 holding.
  • Aptus Capital Advisors first reported a position in iShares US Medical Devices ETF in Q3 2019 and has held it in 28 quarters since.
  • Aptus Capital Advisors's iShares US Medical Devices ETF position peaked at $128K in Q4 2025.
  • 500 funds tracked by Wall St. Rank held iShares US Medical Devices ETF as of Q2 2026.

Based on Aptus Capital Advisors's 13F filing for Q2 2026, filed 12 Aug 2026.